News
GlobalData on MSN1mon
SRC approves opening of TransCode’s fourth cohort in trial of TTX-MC138A US Safety Review Committee (SRC) has granted unanimous approval for TransCode Therapeutics to open the fourth cohort in its ...
TransCode also reported that two additional patients in Cohort 4 are scheduled to receive TTX-MC138. The therapeutic candidate being evaluated, TTX-MC138, is TransCode's lead candidate designed to ...
First patient in Cohort four has been treated with TTX-MC138 Ten patients have been treated with TTX-MC138 at escalating dose levels Additional patients being evaluated for eligibility for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback